Furthermore, siRNA-mediated knockdown of PBX1 in SUP-HD1 cells resulted in reduced TLX2 expression levels, supporting that TLX2 represents an additional target gene activated by PBX1 in HL (Fig 4B). This evidence concerns the gene TLX2 and Hodgkins lymphoma.